Technology | July 25, 2011

RFID Tracking and Verification System Featured at AAPM

July 25, 2011 – Civco Medical Solutions is showcasing its RFSuite radio frequency identification (RFID) tracking and verification system at the annual meeting of the American Association of Physicists in Medicine (AAPM). Civco also is hosting an RFSuite Symposium, from 12:30 – 2 p.m Monday, Aug. 1, in the Mackenzie Ballroom at the Fairmont Waterfront, Vancouver. The event will include lunch. Pre-registration is required, and spots are still available.

The symposium will include several speakers experienced with RFID technology, including Todd Pawlicki, Ph.D., director of medical physics and clinical operations at Moores Cancer Center in San Diego, Calif., and Alfredo Siochi, Ph.D., assistant professor and director of medical physics education in the department of radiation oncology at the University of Iowa Hospital and Clinics in Iowa City, Iowa. Moores Cancer Center has been using Civco’s RFSuite for nearly a year.

Civco will also sponsor an RFID and workflow consortium at AAPM to learn more about the clinical benefits of RF technology.  

The RFSuite system uses RFID technology to track patients, staff and equipment and to provide accessory and patient identity verification for treatment. “The use of RFID technology provides real-time information about resource availability and pending tasks,” said Siochi. “Schedule optimization could match resources to tasks and in our RFID simulation study, this reduced patient wait times by 30 minutes.”

The RFSuite software, RFTrak, provides a snapshot of where people and items are located in a facility in real time, improving workflow and reducing patient wait time. Civco’s RFSeries line provides a broad array of RFID enabled products.

“RFID technology is uniquely positioned to have a major impact in radiation oncology,” said Pawlicki. “In addition to equipment and resource tracking, RFID will provide the real-time process data that can be used as the basis for comprehensive performance and safety programs. We look forward to working with Civco in developing its RFID technology as a key component of our data-driven improvement approaches, such as Lean or Six Sigma.”

For more information: www.Civco.com

Related Content

User's of Varian's 360 Oncology platform can see all of their current patients and associated tasks at a glance when they log in

User's of Varian's 360 Oncology platform can see all of their current patients and associated tasks at a glance when they log in.

Feature | Oncology Information Management Systems (OIMS) | September 08, 2017 | By Jeff Zagoudis
Cancer is perhaps the most highly personal, complex disease in our world today.
more healthcare providers and patients are choosing options such as Gamma Knife stereotactic radiosurgery
News | Radiation Therapy | July 31, 2017
Each year, up to 650,000 people who were previously diagnosed with various forms of cancer will develop brain...
Elekta’s MR-linac integrates an advanced linear accelerator and a 1.5T magnetic resonance imaging (MRI) system

Elekta’s MR-linac integrates an advanced linear accelerator and a 1.5T magnetic resonance imaging (MRI) system. Combined, these systems will allow for simultaneous radiation therapy delivery and high-field MR tumor monitoring.

Feature | Radiation Oncology | July 05, 2017 | By Jeff Zagoudis
Image-guided radiation therapy offers great potential to improve the efficiency of treating cancer patients by more...

Photo courtesy of RaySearch

Feature | Treatment Planning | July 05, 2017 | By Jeff Zagoudis
While radiation oncologists have a number of proven techniques at their disposal for treating patients, the reality is...
Dual-labeled PSMA-inhibitors for the diagnosis and therapy of prostate cancer

IMAGE OF THE YEAR: Dual-labeled PSMA-inhibitors for the diagnosis and therapy of prostate cancer. Technology of dual-labeled PSMA-inhibitors for PET/CT imaging and fluorescence-guided intraoperative identification of metastases. This work might help to establish a new treatment regimen for more precise and sensitive pre-, intra- and post-therapeutic detection of prostate cancer.

Credit: Courtesy of A. Baranski, M. Schäfer, U. Bauder-Wüst, M. Roscher, J. Schmidt, E. Stenau, L. Maier-Hein, M. Eder, K. Kopka, German Cancer Research Center, Heidelberg, Germany; T. Simpfendörfer, B. Hadaschik, U. Haberkorn, Heidelberg University Hospital, Heidelberg, Germany; PET-image: Afshar-Oromieh et al., EJNMMI 2013; 40(4); STED-image: J. Matthias, German Cancer Research Center.

This study was supported by the VIP+ fund, Federal Ministry of Education & Research (BMBF), Germany.

Scientific Paper 531: “Preclinical evaluation of dual-labeled PSMA-inhibitors for the diagnosis and therapy of prostate cancer.” A. Baranski, M. Schäfer, U. Bauder-Wüst, M. Roscher, J. Schmidt, E. Stenau, L. Maier-Hein, M. Eder, K. Kopka, German Cancer Research Center (DKFZ), Heidelberg, Germany; T. Simpfendörfer, B.  Hadaschik, U. Haberkorn, University Hospital, Heidelberg, Germany. Presented at SNMMI’s 64th Annual Meeting, June 10-14, 2017, Denver, Colo.

News | Prostate Cancer | June 15, 2017
In the battle against metastatic prostate cancer, the removal of lymph node metastases using image-guided surgery may...
Versa

Image courtesy of Elekta

News | Radiation Therapy | June 13, 2017
Radiation therapy (RT) using high-energy particles, like X-rays or electron beams, is a common and critical component...
News | Radiation Oncology | June 12, 2017
The alliance will study the feasibility of using CRnR’s converging x-ray lens technology as an effective radiotherapy...
stereotactic body radiation therapy (SBRT)
News | Stereotactic Body Radiation Therapy (SBRT) | June 12, 2017
The American Society for Radiation Oncology (ASTRO) issued a new clinical guideline for the use of stereotactic body...
Sponsored Content | Case Study | Radiation Therapy | June 08, 2017
Stereotactic body radiation therapy (SBRT) employs significantly higher per fraction radiation doses than conventional...
pediatric imaging
News | Radiation Oncology | June 08, 2017
In an article published in the June 2017 issue of The Journal of Nuclear Medicine, researchers assert that e
Overlay Init